Association Bone Schintigraphy with Prostate Spesific Antigen, Gleason score, and Grade group in Prostate Cancer Patient

Penulis

  • Harahap, RR Nuclear Medicine and Theranostic Molecular, Hasan Sadikin General Hospital
  • Kartamihardja, AHS Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital
  • Hidayat, B Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital
  • Budiawan, H Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital
  • Darmawan, B Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital
  • Soeriadi, EA Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital

DOI:

https://doi.org/10.29303/jku.v10i4.620

Kata Kunci:

Prostate Specific Antigen, Gleason score, Grade group, prostate cancer, bone metastasis, Tc-99m MDP bone scintigraphy

Abstrak

Latar Belakang. Kanker prostat yang telah mengalami metastasis (terutama di tulang) sering tidak terdiagnosis dengan baik dan memiliki prognosis yang kurang baik. Sehingga, sangatlah penting dilakukan pemeriksaan dini dalam mendeteksi metastasis. Indikator pemeriksaan sidik tulang yang sering dipakai adalah kadar prostate specific antigen (PSA) dan gleason score (GS). Penelitian ini bertujuan untuk menganalisis seberapa kuat faktor-faktor tersebut dalam mempengaruhi kejadian metastasis tulang pada kanker prostat

Subjek dan metode. Penelitian retrospektif analistik dengan rancangan potong lintang pada 189 data rekam medis pasien kanker prostat yang menjalani pemeriksaan sidik tulang Tc-99m MDP di RSUP Dr. Hasan Sadikin periode januari 2012 sampai desember 2016. Data PSA, GS dan gleason grade (GG) dianalisa secara bivariate dan multivariate.

Hasil. Dari 189 data rekam medis hanya 110 rekam medis yang masuk dalam kriteria inklusi. Dari hasil analisa bivariate, hanya PSA (p = < 0,001) yang memiliki asosiasi bermakna dengan kejadian metastasis tulang, namun semakin tinggi derajat GS maupun GG maka kemungkinan metastasisnya semakin tinggi (GS p= 0,054 dan p= 0,036). Dari analisa multivariate, PSA tetap menjadi faktor yang paling kuat asosiasinya dengan kejadian metastasis tulang pada kanker prostat dengan nilai p = 0.001.

Simpulan. Dari analisa bivariate dan multivariate, kadar serum PSA memiliki asosiasi terhadap kejadian metastasis tulang pada pasien kanker prostat. Pada klasifikasi berdasarkan GS dan GG, semakin tinggi GS ataupun GG semakin tinggi pula kejadian metastasis tulangnya. Sehingga, hasil tersebut dapat membantu dalam mengidentifikasi pasien kanker prostat yang memiliki risiko tinggi untuk terjadinya metastasis tulang.

Biografi Penulis

Harahap, RR, Nuclear Medicine and Theranostic Molecular, Hasan Sadikin General Hospital

PENDIDIKAN FORMAL

1990 – 1996    SD Kemala Bhayangkari 1, Medan

1997 – 2000    SMP Harapan 2, Medan

2001 – 2003    SMA Negeri 1, Medan

2004 – 2011    Fakultas Kedokteran Universitas Sumatera Utara

PENGALAMAN KERJA

2011 – 2013    Dokter Umum di Klinik Fatimah, Medan

2011 – 2013    Dokter Umum di IGD RS Siti Hajar Medan 

KARYA ILMIAH

  1. Determining the Theraphy Dose of Radioactive Iodine in Patienst with Hyperthyroidism (High Uptake) with Smoking History
  2. Kejadian Metastasis Tulang Pada Kasus Adenokarsinoma Prostat Berdasarkan Sidik Tulang 99mTc-MDP dan Grade Group

Kartamihardja, AHS, Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital

Penelitian

  1. Kartamihardja AHS. Current Status of Hepatocellular Carcinoma in Indonesia. Presented on IAEA Regional Training Workshop on Radionuclide Treatment of Liver Cancer, Singapoe 14-18 Feb 2000. (Tinjauan Pustaka)
  2. Kartamihardja AHS.   Tc-99m Sestamibi Scintimammography in the Diagnosis of Breast Cancer. Presented in IAEA-PAEC Regional Workshop on Scintimammography, Sentinel Lymph node Detection and Intraoperative Surgical Probe Technology in the Management of Breast Cancer. Islamabad, Pakistan, 9-13 April 2001.(Tinjauan Pustaka)
  3. Kartamihardja AHS. Pelayanan Kedokteran Nuklir Melalui Kerjasama Operasional (KSO) di RSUP Dr. Hasan Sadikin Bandung. Disampaikan pada Semiloka Pengembangan Pelayanan Kedokteran Nuklir dan Radioterapi sebagai Profit Center di Rumah Sakit, Jakarta, 31 Mei 2001.(Tinjauan Pustaka)
  4. Kartamihardja AHS. Penggunaan radionuklida pada pencitraan perfusi dan evaluasi viabilitas miokard. Disampaikan pada Pertemuan Ilmiah Tahunan Perhimpunan  Dokter  Spesialis  Radiologi  Indonesia,  Yogyakarta,  14  Juli 2001.(Tinjauan Pustaka)
  5. Kartamihardja   AHS.   The   Role   of   Nuclear   Medicine   on   Pulmonary Embolism. Presented in IAEA-INMO Advanced National Training Course on Nuclear Medicine, We Madani, Sudan 3-7 Nov 2001.(Tinjauan Pustaka)
  6. Kartamihardja AHS. Nuclear Medicine in Paediatric. Presented in IAEA- INMO  Advanced  National  Training  Course  on  Nuclear  Medicine,  We Madani, Sudan 3-7 Nov 2001.(Tinjauan Pustaka)
  7. Kartamihardja AHS. The Role of Nuclear Medicine on Infection and Inflammation.  Presented  in  IAEA-INMO  Advanced  National  Training Course on Nuclear Medicine, We Madani, Sudan 3-7 Nov 2001.(Tinjauan Pustaka)
  8. Kartamihardja AHS. Myocardial Perfusion Imaging. Presented in IAEA- INMO Advanced National Training Course on Nuclear Medicine, Wed Madani, Sudan 3-7 Nov 2001.(Tinjauan Pustaka)
  9. Kartamihardja AHS. Peranan Teknik Kedokteran Nuklir dalam Penentuan Fokus Infeksi. Kumpulan Makalah Pertemuan Dwi Tahunan PKBNI-PKNI- BATAN 2002.(Tinjauan Pustaka)
  10. Kartamihardja AHS. Peranan Teknik Kedokteran Nuklir dalam Bidang Kesehatan. Disampaikan Seminar Pendayagunaan Reaktor TRIGA dalam Mendukung Program Pembangunan Nasional. Bandung, 4 Februari 2002.(Tinjauan Pustaka)
  11. Kartamihardja AHS. Aspek klinis radioisotop/senyawa bertanda dalam kedokteran. Disampaikan pada Pelatihan Teknologi    Proses  Produksi Radioisotop dan Senyawa Bertanda. Bandung, 5-16 Agustus 2002.(Tinjauan Pustaka)
  12. Kartamihardja AHS. Peranan Teknik Kedokteran Nuklir dalam Penentuan Fokus Infeksi. Disampaikan pada Pertemuan Ilmiah PKBNI/PKNI, Jakarta 18-19 September 2002.(Tinjauan Pustaka)
  13. Kartamihardja AHS, Current Status of Nuclear Medicine on Oncology in Indonesia. Disampaikan pada ARCCNM Symposium, Jakarta, September 2003.(Tinjauan Pustaka)
  14. Kartamihardja AHS, Peranan Kedokteran Nuklir dalam Diagnosis dan Follow-up Penderita Penyakit            Jantung. Disampaikan pada Semiloka Kedokteran Nuklir, Yogyakarta, 12 Juni 2004. (Tinjauan Pustaka)
  15. Kartamihardja AHS, Peranan Kedokteran Nuklir pada Nefro-urologi. Disampaikan pada Seminar Pendayagunaan           Kedokteran Nuklir untuk Pelayanan Kesehatan Ginjal Jakarta, 20 Agustus 2004.(Tinjauan Pustaka)
  16. Kartamihardja AHS, Mekanisme Lokalisasi Radiofarmaka. Disampaikan pada Pelatihan Radiofarmasi untuk Staf Pengajar Farmasi   Perguruan Tinggi Serpong-Jakarta 28 September 2004. (Tinjauan Pustaka)
  17. Kartamihardja AHS, Interpretasi hasil pencacahan dan pencitraan radionuklida. Disampaikan pada Pelatihan Radiofarmasi untuk Staf Pengajar Farmasi Perguruan Tinggi Serpong-Jakarta 28 September 2004. (Tinjauan Pustaka)
  18. Kartamihardja AHS. Peranan Kedokteran Nuklir dalam Pengelolaan Penyakit Ginjal dan Saluran Kemih. Disampaikan pada Seminar Pemasyarakatan hasil penelitian teknologi nuklir BATAN, RSUD Dr. Slamet, Garut 22 Maret 2005.
  19. Kartamihardja  AHS.  Aplikasi  Teknik  Nuklir  dalam  Bidang  Kedokteran. Disampaikan  pada  Diklat  Introduksi  Teknik  Nuklir  bagi  Guru  SMU  di Bandung. Juli 2005.
  20. Kartamihardja AHS. The Role of Nuclear Medicine on Detection and Localization of Infection and Inflammation. Disampaikan pada Konas PDSRI, Jogyakarta, Juli 2005.
  21. Kartamihardja AHS. Nuclear Oncology in Indonesia. Disampaikan pada Lunch Symposia” Peranan Kedokteran Nuklir Pada Penatalaksanaan Tumor. Jakarta, 21 September 2005.
  22. Kartamihardja AHS. Peranan Kedokteran Nuklir dalam Nefrourologi. Disampaikan           pada Seminar dan Pemeriksaan Ginjal ”Pemanfaatan Teknologi Kedokteran Nuklir di Bidang Nefrologi”. Jakarta, 29-30 Nopember 2005.
  23. Kartamihardja AHS. Pencitraan Tc-99m Cyprofloxacine dibandingkan dengan Tc-99m HMPAO-WBC pada Penderita Infeksi Tulang dan Sendi. 2006; XXXVIII (2): 59-65. (Penelitian)
  24. Kartamihardja AHS. Pencitraan dengan Radionuklid Tc-99m-Ethambutol untuk Diagnosis Tuberkulosis Extra Pulmonal (Penelitian pada hewan percobaan). 2006; XXXVIII (3): 116-121.(Penelitian).

 

Pelatihan dan Fellowship

  1. Workshop on Quality Control of Nuclear Medicine Instruments, IAEA- BATAN Bandung, Indonesia, April 1985.
  2. Post Graduate Training Course on Nuclear Medicine, ANSTO-RPAH Sydney, Australia 1985 - 1986.
  3. Training Course on Nuclear Medicine Data Processing, Nagoya Cancer Centre, Japan, April 1986.
  4. Regional Train-the Trainers Course on Data Processing in Radioimmunoassay, IAEA-BATAN, Jakarta Indonesia, Juli 1987.
  5. Workshop on Radio-aerosol Inhalation Lung Imaging in Developing Countries, IAEA-BARC Bombay, India 1987.
  6. Interregional Training Course on Nuclear Medicine, IAEA-CIAMS, Moscow-USSR, September – Nopember 1987.
  7. The National Course on the Application of Nuclear Technique in Medicine, BATAN-ANSTO-RSHS, Bandung 1988.
  8. Training on SPECT Camera, RoosvilleHospital, San Jose, USA, 1988.
  9. Workshop on Liver Imaging, IAEA-Seoul Catholic Hospital, Seoul, Korea, 1989.
  10. Regional Training Course on the Use of Computer in Nuclear Medicine, IAEA-ANSTO, Sydney Australia, 1990.
  11. Training Course on Nuclear Medicine, Dept. of Nuclear Medicine, St. Germain en Laye Hospital, Paris, Perancis, 1994.
  12. Fellowship on Nuclear Medicine, IAEA-St. Bartholomews Hospital, London UK, 1995 - 1996.
  13. RCA Training Course  on  Application of  Positron  Emission  Tomography (PET) in Clinical Practice for Nuclear Medicine Physicians. IAEA- Cardiovascular Institute Fu Wai Hospital. Beijing, China, 2000.
  14. RCA Training Workshop on Scintimammography, Sentinel Lymph Node Detection and Intra-Operative Surgical Probe Technology, IAEA-NORI, Islamabad, Pakistan, 2001.
  15. RCA Training Course on Myocardial Perfusion Scintigraphy for Nuclear Medicine Physicians. IAEA-NIRS Chiba, Japan, 2003.
  16. RCA Training Course on Interventional Nuclear Medicine. IAEA-New Delhi, India, 2003.
  17. Pelatihan Pengadaan barang/jasa pemerintahan (Kepres nomor 80 tahun 2003). LBI- Jakarta 2004.
  18. Pelatihan dan Ujian Nasional Sertifikasi Pengadaan barang/jasa pemerintahan (Kepres nomor 80 tahun 2003), Surabaya, April 2005.
  19. IAEA/RCA Project Planning  Meeting on “Tumour Imaging Using Radioisotopes” Chiba, Japan, April 2005.
  20. RCARO/UNDP Regional Training Course on SPECT/PET Imaging Science and Technology, Seoul, Korea, 18 – 23 June 2012

 

Jabatan

  1. Koordinator Program Studi Ilmu Kedokteran Nuklir FK UNPAD pada tahun 2014 – sekarang
  2. Ketua Kolegium Perhimpunan Kedokteran Nuklir Indonesia : tahun 2006 –sekarang
  3. Penasehat  Perhimpunan  Kedokteran  Nuklir  Indonesia   :  tahun  2013  –sekarang
  4. Penasehat Perhimpunan Kedokteran Nuklir dan Biologi Indonesia  : tahun 2013 – sekarang.
  5. Country Principal of Asian School of Nuclear Medicine
  6. Editorial Board of World Journal of Nuclear Medicine
  7. Editorial Board of Asia Oceania Journal of Nuclear Medicine

Hidayat, B, Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital

1.

Perancangan Hewan Coba Model untuk Karsinoma Payudara

Dr. Basuki Hidayat, dr, SpKN(K)

MKB, Vol 48, No. 1 Maret 2016

2016

2.

Differential Diagnosis Of Diffuse Bone Marrow Uptake On 18f-Fdg Pet/ Ct

Dr. Basuki Hidayat, dr, SpKN(K)

Int J Clin and Biomed Res. 2016;2(1): 1-5

 

2016

3.

Automated Bone Scan Index as Predictor of Survival in Prostate Cancer.

Dr. Basuki Hidayat, dr, SpKN(K)

World Journal of Nuclear Medicine

World Journal of Nuclear Medicine

2017;16: 266-70

2016

4.

Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer

Dr. Basuki Hidayat, dr, SpKN(K)

World Journal of Nuclear Medicine

2017;16:81-4.

2017

5.

The Review of Tc-99m application in Diagnostic Procedures and Internal Radiation Dose Estimation

Dr. Basuki Hidayat, dr, SpKN(K)

proceeding of 2nd Nuclear Energy Seminar, 2015

 

2015

6.

Roles of Microwave Oven in Preparation of Microbiological Growth Media

 

Dr. Basuki Hidayat, dr, SpKN(K)

Althea Medical Journal

2016

7.

Applicaton of 99m Tc radioisotope in diagnostic procedures and internal radiation dose estimation

Dr. Basuki Hidayat, dr, SpKN(K)

KNE energy, International Conferences of Nuclear Energy Technologies and Science

2015

8.

Studi awal estimasi internal 177 Lu-Dota Trastuzumab pada manusia berbasis uji biodistribusi pada mencit

Dr. Basuki Hidayat, dr, SpKN(K)

Indonesian Journal of Nuclear Science and Technology 2015

2015

9.

Generalized lymphadenopathy due to chronic lymphocitic leukemia (CLL): 18F-FDG PET imaging

Dr. Basuki Hidayat, dr, SpKN(K)

Journal of Medicine and Helath 2016

2016

10.

Effect of Radioiodine (I-131) to TSH, T3 and fT4 Hormone Levels in Hypertiroidism high uptake patients

Dr. Basuki Hidayat, dr, SpKN(K)

Trends Med Res, 12(1): 14-19,2017

2017

11.

Studi dosimetri internal radiofarmaka terapi kanker payudara 177Lu-DOTA-Trastuzumab

Dr. Basuki Hidayat, dr, SpKN(K)

Jurnal keselamatan radiasi dan lingkungan 2016

2016

 

Budiawan, H, Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital

Karya Ilmiah
Original article :
1. Hendra Budiawan, Basuki Hidayat, A Hussein S Kartamihardja, Johan S Masjhur. The
correlation between transient ischemic dilation (TID) ratio with HbA1c value in type
diabetes mellitus patients who also present with metabolic syndrome. World J Nucl Med
2009; 8:165-171.
2. Hendra Budiawan, Gi Jeong Cheon, Hyung-Jun Im, Soo Jin Lee, Jin Chul Paeng, Keon
Wook Kang, June-Key Chung, Dong Soo Lee. Heterogeneity Analysis of 18F-FDG Uptake
in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma
of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.
Nucl Med Mol Imaging 2013; 47:232–241. doi: 10.1007/s13139-013-0216-6. Epub 2013
Aug 21. PMID: 24900118 [PubMed]
3. Hendra Budiawan, Ali Salavati, Harshad R Kulkarni, Richard P Baum. Peptide receptor
radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium
and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis.
Am J Nucl Med Mol Imaging 2014; 4(1):39-52. eCollection 2013. PMID: 24380044
[PubMed]
Abstract :
1. Hendra Budiawan, Inki Lee, Jee Youn Moon, Gi Jeong Cheon, Yong Chul Kim, Jin Chul
Paeng, Keon Wook Kang, June-Key Chung, Dong Soo Lee. The value of bone SPECT/CT
to identify causing lesions and guide to pain control in patients with chronic low back
pain. J Nucl Med. 2014; 55 (Supplement 1):94.
2. Hendra Budiawan. Role of FDG in primary lesion identification ( a preliminary result).
Presented in 4th International Conference on Radiopharmaceutical Therapy 2011 in
Conjunction with 10th AGM of Asian Regional Cooperative Council for Nuclear
Medicine, Ho Chi Minh City Vietnam, 2011.
3. Hendra Budiawan, Basuki Hidayat, Achmad Hussein S Kartamihardja, Johan S Masjhur,
Eko Purnomo. Transient ischemic dilation: Is it due to systolic dysfunction or
subendocardial ischemia? World Journal of Nuclear Medicine; v. 6(suppl.1); ISSN 1450-
1147; Jul 2007; S82-S83.
4. Achmad Hussein S Kartamihardja, Agus H Rahim, Heda Melinda, Hendra Budiawan, A
Sulistiani. Tc-99m-ethambutol imaging for detection of tuberculosis. World J Nucl Med.
2006; 5(Suppl 1):S54.

Darmawan, B, Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital

Jabatan yang sedang dan pernah dikerjakan :
1. Koordinator Pelayanan di Bagian/UPF Ilmu Kedokteran Nuklir FK Unpad/RSUP Dr.
Hasan Sadikin
2. Ketua Program Studi Ilmu Kedokteran Nuklir FK Unpad
3. Sekretaris Umum PB Perhimpunan Kedokteran Nuklir Indonesia
4. Ketua Panitia Pekan Ilmiah Tahunan PKNI-PKBNI 2011
5. Tenaga Dosen Tidak Tetap di Fakultas Kedokteran Unpad
6. Tenaga Dosen Tidak Tetap di Poltekes RS Al Islam Bandung
7. Anggota Pasien Safety di RSUP Dr. Hasan Sadikin
8. Konsultan Kedokteran Nuklir RS Kanker Darmais Jakarta
Pendidikan dan Pelatihan yang telah diikuti Dalam dan Luar Negeri :
1. Seminar Pengenalan Dasar USG Untuk Alumni Fakultas Kedokteran Universitas
Trisakti, Jakarta, 18 Nopember 2000
2. Pelatihan “Dokter Triase Dalam Penatalaksanaan Penderita Gawat Darurat Terpadu”,
18-25 Juni 2002, RSUP Dr. Hasan Sadikin, Bandung
3. Pekan Ilmiah Dwi Tahunan “Optimasi Pengembangan dan Pelayanan Kedokteran
Nuklir Bagi Kesejahteraan Rakyat, 18-19 September 2002, Jakarta
4. Seminar Sehari Penanganan TB Paru, Subang, 4 Oktober 2000
5. Pelatihan Penanggulangan Kebutaan Katarak Terpadu Kabupaten Subang, Subang,
22-24 Juni 2000
6. Seminar Sehari Mata Merah dan Kebutaan, Bandung, 21 April 2001
7. Seminar ISNM-ISNMB and 1st Organizing Committee Meeting of ARCCNM,
Jakarta 28-29 September 2003
8. Kursus EKG, Bandung, 15-18 Desember 2003
9. Simposium Sehari Asthenia and It’s Management, Bandung, 22 Maret 2003
10. National Congress of Indonesian Society of Nuclear Medicine and Biology, Jakarta,
10-11 December 2004
11. One Day Seminar Oncology Radiation, Bandung, 14 Agustus 2004
12. Forum Diabetes Nasional III, Bandung, 15-17 Juli 2005
13. Symposium on The Role of Nuclear Medicine in Cerebro-cardiovascular Diseases
and Malignancies, Bandung, 26 February 2005
14. The Annual Scientific Meeting 2007 on Anticipation of Upcoming PET Era in
Indonesia, Bandung, 3-4 March 2007.
15. Temu Ilmiah International Standards of Tuberculosis Care, 13 Maret 2009, Bandung
16. Symposium : What’s New on cancer Prevention, Detection and Management,
Bandung, 9 march 2007
17. Pekan Ilmiah Tahunan Tahun Emas Fakultas Kedokteran Universitas Padjadjaran,
Bandung, 9-10 Nopember 2007
18. Workshop Bioetika dan Humaniora, 20 Nopember 2008, Bandung
19. Pain Workshop : Recent Advances : New Paradigm in Pain Management, Bandung, 9
Agustus 2008
20. National Congress, The Indonesian Society of Nuclear Medicine VI, The Indonesian
of Nuclear Medicine and Biology VIII, Colaboration with The Asian School of
Nuclear Medicine, Bandung, 04 December 2008
21. Symposium Multidisciplinary Approach in the Treatment of Glioma, Jakarta, 26
January 2008
22. Simposium Endokrinologi Klinik VII 2009, Bandung, 23-25 January 2009
23. Pelatihan Pelayanan Keselamatan Pasien Rumah Sakit, RSUP Dr. Hasan Sadikin,
Bandung, 22-24 April 2009
24. Pelatihan Coaching Radioisotop dalam Farmasi dan Kedoktera, Bandung, 4 Mei – 31
Juli 2009
25. Workshop Penyusunan Pedoman Clinical Pathway, Bandung, 15-16 Mei 2009
26. Pelatihan Penyegaran Proteksi Radiasi dan Keselamatan Kerja, 15-19 Juni 2009,
BATAN-Bandung
27. Research Ethics and Good Clinical Practice Training, 10-12 July 2009, Bandung
28. Pendidikan dan Pelatihan Pengelolaan Penderita Gawat Darurat, 23-30 Juli 2009,
RSUP Dr. Hasan Sadikin, Bandung
29. Pelatihan Etika dan Hukum Kesehatan, 6-8 Oktober 2009, RSUP Dr. Hasan Sadikin,
Bandung
30. Nuclear Cardiology Symposium, 13-14 January 2004, Singapore
31. 8th Asia & Oceania Congress of Nuclear Medicine and Biology, Beijing, 9-13
October 2004
32. Singapore Live 2007, Singapore, 22-23 January 2007
33. SGH Nuclear Medicine Update 2008, 5-9 March 2008, Singapore
34. IAEA/RCA Regional Training Course on Fundamental Clinical Applications of PET,
Singapore, 20-24 May 2008
35. 9th Asia Oceania Congress of Nuclear Medicine and Biology, New Delhi, India 31
October – 4 November 2008
36. 9th Congress of the World Federation of Nuclear Medicine and Biology, Seoul
Korea, 22-27 October 2009
37. IAEA/RCA Regional Training on Advanced Clinical Applications of PET, Chiba,
Japan, 20-24 April 2009
38. IAEA/RCA Regional Training on Advanced Clinical Applications of PET, Australia,
Juli 2013
39. IAEA/RCA Regional Training on Advanced Clinical Applications of PET, Seoul
Korea, November 2013
40. IAEA/RCA Training QUANUM, Singapore, Desember 2013
PEMBICARA DAN POSTER :
1. The Annual Scientific Meeting 2009, The Indonesian Society of Nuclear Medicine, The
Indonesian Society of Nuclear Medicine and Biology and The 8th Annual general
Meeting of Asian Regional Cooperative Council For Nuclear Medicine, Yogyakarta, 20-
21 November 2009 (judul: Non-osseous Uptake in Breast Cancer).
2. National Congress The Indonesian Society of Nuclear Medicine VI The Indonesian
Society of Nuclear Medicine and Biology VII Colaboration with The Asian School of
Nuclear Medicine Bandung, 4-6 December 2008
3. Symposium Fisika Nuklir Indonesia, Oktober 2009
Judul: Hybrid Imaging
4. 8th Asia & Oceania Congress of Nuclear Medicine and Biology, Beijing,
9-13 October 2004.
5. 9th Congress of the World Federation of Nuclear Medicine and Biology, Seoul Korea,
22-27 October 2009.
6. Pekan Ilmiah Tahunan PKNI/PKBNI, Bandung 3-4 November 2011.
judul: Nuklir Tiroidologi.
7. Pekan Ilmiah Tahunan PKNI/PKBNI, Jakarta 11-12 November 2012
Judul: Radioactive Iodine (RAI) in the management of Differentiated Thyroid
Carcinoma.

Soeriadi, EA, Nuclear Medicine and Theranostic Molecular Department, Hasan Sadikin General Hospital

Pengalaman Kerja

? Tahun 2002 – 2003
Dokter Umum Instalasi Gawat Darurat Rumah Sakit Pakuwon Sumedang
? Tahun 2003 – 2006
Menyelesaikan masa bakti PTT di Kabupaten Sumedang
? Tahun 2003 – 2007
Kepala Unit Transfusi Darah PMI Cabang Sumedang.
? Tahun 2006-2009
Dokter Umum di Bagian Pelayanan Medik dan Unit Diabetes Rumah Sakit Pakuwon
? 2012-Sekarang
Staf di Bagian Kedokteran Nuklir, RS. Dr. Hasan Sadikin, Bandung
Pelatihan
? Tahun 2005
Pelatihan dan Pengelolaan Gawat Darurat di Rumah Sakit Dr. Hasan Sadikin.
? Tahun 2008
Diabetes Management Course for Primary Care Physician, International Diabetes Federation Curriculum, Indonesia Diabetes Association, Bogor.

? Tahun 2011
RCARO/UNDP Regional Training Course on SPECT/PET Imaging Science and Technology, Seoul, Korea
? Tahun 2015
Workshop on Nuclear Medicine in Pediatric, IAEA, Manila, Philipines
? Tahun 2016
Regional Training Course in Nuclear Cardiology, IAEA, Kuwait City, Kuwait.

Seminar Ilmiah
? November 2009
Seminar dan Workshop : ‘Implementation Cancer Control Programe Accelerating Integrated System in Cancer Treatment’, Rumah Sakit Kanker Dharmais, Jakarta.
? November 2009
The 8th Annual Meeting Asean Regional Cooperative Council of Nuclear Medicine (ARCCNM), Yogyakarta, Indonesia.
Oktober 2010
Seminar Hukum Kesehatan, Isu Mutakhir Hukum (UU Pornografi), Bidang Kesehatan (Nuklir) dan Hukum Kesehatan (Rekam Medik), Bandung.
? Tahun 2010
Molecular Imaging, Mochtar Riady Comprehensive Cancer Centre (MRCCC), Jakarta.
? Desember 2010
9th Annual Meeting of Asean Regional Cooperative Council of Nuclear Medicine and 16th National Conference of Society of Nuclear Medicine Bangladesh, Dhaka, Bangladesh.
? Maret 2011
Nuclear Medicine Update and Radionuclide Therapy, Singapore
Pertemuan Ilmiah Tahunan Ilmu Kedokteran Nuklir, Bandung, Indonesia
? Tahun 2012
Pertemuan Ilmiah Tahunan Ilmu Kedokteran Nuklir, RS Kanker Dharmasi, Jakarta, Indonesia
? Tahun 2013
Pertemuan Ilmiah Tahunan Ilmu Kedokteran Nuklir, RS Mochtar Ryadi Comprehensive Cancer Centre, Jakarta, Indonesia
? Tahun 2014
Pertemuan Ilmiah Tahunan Ilmu Kedokteran Nuklir, RS Kariadi, Semarang, Indonesia
Annual Meeting of ARCCNM, Osaka, Jepang

? Tahun 2015
Pertemuan Ilmiah Tahunan Ilmu Kedokteran Nuklir, RSUP Dr. Hasan Sadikin, Bandung, Indonesia
Karya Tulis Ilmiah
? Oktober 2008
Bentuk Badan Hukum Perseroan Terbatas bagi Rumah Sakit Swasta, tesis Program Pasca Sarjana, Program Studi Magister Hukum Konsentrasi Hukum Kesehatan, Universitas Katolik Soegijapranata, Semarang.
? 2010
Discordance Between Tc-99m Ethambutol Scintigraphy and Conventional Diagnostic Modalities on Extra Pulmonary Tuberculosis
? 2011
I-131 Therapy for Pediatric Hyperthyroid;
A Clinical Experience in Nuclear Medicine Department, Dr. Hasan Sadikin Hospital, Indonesia
? 2013
Perbedaan Penangkapan Tc-99m DTPA pada Mata Aktif dan Tidak Aktif Berdasarkan Clinical Activity Score (CAS)
Organisasi
? Tahun 2002-2009
Pengurus Ikatan Dokter Indonesia (IDI) Cabang Sumedang.
? Tahun 2005-2009
Anggota Persatuan Diabetes Indonesia (Persadia).
? Tahun 2009 – Sekarang
Anggota Ikatan Dokter Indonesia Cabang Bandung
Anggota Perhimpunan Kedokteran dan Biologi Nuklir Indonesia (PKBNI).
? Tahun 2010 – Sekarang
Anggota World Association of Radiopharmaceutical and Molecular Therapy (WARMTH).
? 2013-Sekarang
Anggota Perhimpunan Kedokteran Nuklir Indonesia
? 2016 – sekarang
Anggota American Society of Nuclear Cardiology

Referensi

1. Ferley J. Shin HR, Bay F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Komite Penanggulangan Kanker Nasional. Panduan penatalaksanaan Kanker Prostat. Edisi ke-1 2015; 1-23.
3. Kelompok Kerja Kanker Urologi RS. Cipto Mangunkusumo – RS Kanker Dharmais. Panduan pengelolaan kanker prostat. Interna Publishing 2009
4. Umbas R, Safriadi F. Karakteristik dan Pola penanganan kanker prostat di RS. Dr Hasan Sadikin, Bandung. Indones J Cancer.
5. R. D. Rubens and I. Fogelman (EDS.). Bone Metastases, Diagnosis and Treatment. Springer-verlag London Limited 1991.
6. McGregor B, Tulloch A, Quinlan M. The role of bone scanning in the assessment of prostatic carcinoma. Br J Urol 1978; 50: 178-181.
7. O’Donoghue E, Constable A, Sherwood T. Bone scanning an plasma phosphatase in carcinoma of the prostate. Br J Urol 1978; 50: 172-177.
8. Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Edisi ke-9. Canada: Elsevier Saunders; 2013.
9. Lars E, MD; Roberta M, MD, PhD; Rodolfo M, MD, FRCPath. Implication of the International Society of Urological Pathology Modified Gleason Grading System. Arch Pathol Lab Med – Vol 136, April 2012.
10. Velonas VM, Woo HH, dos Remedios CG, Assinder SJ: Current status of biomarkers for prostate cancer. Int J Mol Sci, 2013; 14: 11034–60
11. Kamaleshwaran KK, Mittal BR, Harisankar CN et al: Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy. Indian J Nucl Med, 2012; 27: 81–84
12. Altuwaijri S. Role of Prostate Specific Antigen ( PSA ) in Pathogenesis of Prostate Cancer. 2012;2012(August):331–6.
13. Mohammes A. Al-Ghazo, et al. Do all Patients with Newly Diagnosed Prostate Cancer Need Staging Radionuclide Bone scan ? A Retrospective Study. International Braz J Urol, Vol. 36 (6): 685-692, November-Desember, 2010. Doi: 10.1590/S1677-55382010000600006
14. Harnden P, Shelley MD, Coles B et al: Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis. Lancet Oncol, 2007; 8: 411–19
15. Edge SB, Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010; 17: 1471–74
16. Yehui Chen, Yun Lin, Pin Nie, et al. Association of Prostate-Spesific Antigen, Prostate Carcinoma Tissue Gelason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Cancer. e-ISSN 1643-3750. Med Sci Monit, 2017; 23; 1768-1774. DOI: 10.12659/MSM.900977
17. Epstein JI. A new contemporary prostate cancer grading system. Pathologica. 2015;107(3–4):205–7.
18. Yasutaka Yamada, Shinichi Sakamoto, Jun Shimazaki, Masahiro Sugiura, et al. Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone Metastasis. Asian Pasific Prostate Society. http://dx.doi.org/10.1016/j.prnil.2017.03.001.
19. Chybowski FM, Keller JJ, Bergstralh EJ, Oesterling JE: Predicting radionuclide bone scan findings in pa¬tients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol. 1991; 145: 313-8.

Unduhan

Diterbitkan

2022-01-22

Cara Mengutip

Harahap, R. R., Sundawa Kartamihardja, A. H., Hidayat, B., Budiawan, H., Darmawan, B., & Soeriadi Koesoemah, R. E. A. (2022). Association Bone Schintigraphy with Prostate Spesific Antigen, Gleason score, and Grade group in Prostate Cancer Patient . Baphomet University : Situs Slot Online Gacor Terbaik Hari Ini Server Thailand Gampang Maxwin 2024, 10(4), 620–628. https://doi.org/10.29303/jku.v10i4.620

Terbitan

Vol 10 No 4 (2021)

Bagian

Penelitian